Cardiology

Aspirin cuts risk of clots, DVT by a third, new study finds

Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new ...

Diseases, Conditions, Syndromes

'Risk calculator' developed for venous thromboses

In Austria, around 15,000 people a year develop a venous thrombosis, the occlusion of a vein that can result in a pulmonary embolism. A clot breaks free from a vein and travels via the bloodstream to the lungs, where it blocks ...

Diseases, Conditions, Syndromes

ISTH: Apixaban non-inferior to conventional treatment for VTE

(HealthDay)—For patients with venous thromboembolism, treatment with oral apixaban is non-inferior to conventional therapy for preventing recurrent venous thromboembolism or death related to venous thromboembolism, according ...

Diseases, Conditions, Syndromes

Subclinical hypothyroidism may not up VTE recurrence risk

(HealthDay)—In the elderly, subclinical hypothyroidism is not associated with significantly increased risk of recurrent venous thromboembolism (rVTE), according to research published online Jan. 27 in the Journal of Thrombosis ...

Diseases, Conditions, Syndromes

Long-term mortality risk low after cerebral vein thrombosis

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the ...

Diseases, Conditions, Syndromes

Low D-dimer cut-off appears to help prevent recurrent events

(HealthDay)—Low cut-off levels used in the D-Dimer-Ultrasonography in Combination Italian Study (DULCIS) resulted in half the recurrent venous thromboembolism (VTE) events that would have occurred using other criteria in ...

Cardiology

Rivaroxaban cuts recurrent blood clots in obese patients

(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published ...

Diseases, Conditions, Syndromes

Low risk of recurrent VTE for upper extremity DVT, SVT

(HealthDay)—Patients with upper extremity deep and superficial vein thrombosis (UEDVT and UESVT) have low risk of recurrent venous thromboembolism (VTE) but high mortality, according to a study published online Feb. 11 ...

page 1 from 2